Serina Therapeutics Change To Inventory Over Time
| SER Stock | 4.79 0.64 15.42% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Serina Therapeutics Performance and Serina Therapeutics Correlation. Serina |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Serina Therapeutics. If investors know Serina will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Serina Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 3.568 | Earnings Share 0.14 | Revenue Per Share 0.787 | Quarterly Revenue Growth 6.286 | Return On Assets (0.45) |
The market value of Serina Therapeutics is measured differently than its book value, which is the value of Serina that is recorded on the company's balance sheet. Investors also form their own opinion of Serina Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Serina Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Serina Therapeutics' market value can be influenced by many factors that don't directly affect Serina Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Serina Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Serina Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Serina Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Change To Inventory Analysis
Compare Serina Therapeutics and related stocks such as Western Digital, Paltalk, and Joint Stock Change To Inventory Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| WDC | 24.9 M | 88 M | 22 M | (4 M) | (143 M) | 306 M | (204 M) | (598 M) | (339 M) | 200 M | (546 M) | (22 M) | (60 M) | 356 M | 373.8 M |
| PALT | (243 K) | (228.5 K) | 52.4 K | 145 K | (394.4 K) | 469.9 K | 324.5 K | 840 K | 18.6 K | 125 K | (835.8 K) | (536.1 K) | (536.1 K) | (482.5 K) | (458.3 K) |
| IRDM | 15 M | 1.6 M | (11.2 M) | (4.6 M) | 251 K | (169 K) | 9 M | (1.9 M) | (7.6 M) | (13 M) | 7.2 M | 3.6 M | (10.2 M) | (51 M) | (48.4 M) |
| VHC | 418.8 K | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| BCE | (23 M) | (126 M) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| RDCM | (1.2 M) | (2.6 M) | (222 K) | 2.1 M | 1.4 M | 311 K | 794 K | (560 K) | 901 K | (1.1 M) | 811 K | (410 K) | 157 K | 552 K | 579.6 K |
Serina Therapeutics and related stocks such as Western Digital, Paltalk, and Joint Stock Change To Inventory description
The increase or decrease in the amount of inventory a company has over a certain period.My Equities
My Current Equities and Potential Positions
| Serina Therapeutics | SER |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | California; U.S.A |
| Exchange | NYSE MKT Exchange |
null 4.79
Additional Tools for Serina Stock Analysis
When running Serina Therapeutics' price analysis, check to measure Serina Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Serina Therapeutics is operating at the current time. Most of Serina Therapeutics' value examination focuses on studying past and present price action to predict the probability of Serina Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Serina Therapeutics' price. Additionally, you may evaluate how the addition of Serina Therapeutics to your portfolios can decrease your overall portfolio volatility.